- Types of Eczema
- Eczema in Children
- Living Well
- Eczema Products
- Get Involved
- For Medical Professionals
The Swiss scientists theorized that the same immune cells that protect us against the normally harmless Malassezia fungus might also play a fundamental role in triggering atopic dermatitis.
While not a cure, Orliderm™ has brought relief to hundreds of children and adults with moderate to severe atopic dermatitis.
The researchers suggest doctors combine basic skincare techniques with cutting-edge treatments to maximize the well-being of their patients.
In the “Golden Age of Eczema,” people with atopic dermatitis have more treatment options than ever before, with even more drugs making their way to pharmacy shelves.
New evidence shows that Lactobacillus-containing probiotic strains may reduce disease severity in children age 3 and under.
Dermatologists discuss the potential efficacy of prescribing an opioid antagonist to address the problem of itch in atopic dermatitis.
A new, nonsteroidal topical cream for AD called Jakafi (ruxolitinib) may soon hit pharmacy shelves.
Integrative medicine is gaining traction in the health care field, specifically the idea of balancing conventional treatments with complementary therapies for a whole-body approach to treating eczema.
Off-label use of biologic treatments for atopic dermatitis may double the risk for serious infection compared to systemic treatments, researchers found.
The first biologic for treating moderate to severe atopic dermatitis was just approved for teens.